通过MARS®平台分选 CD3- CD56+ NK 细胞

NK细胞是目前肿瘤免疫治疗领域主要的创新目标。开发和改造基于NK细胞的癌症免疫疗法需要清洁且高效的小体积和大规模的细胞分离方法。创新产品MARS®Bar系统为CD56+/CD3-细胞分离提供了新一代大规模、磁分离技术,可以从单采血、全血或骨髓细胞制品中进行分离。

CD3- CD56+ NK Cell Selection with MARS® Platform

NK cells are currently a major target of innovation in the field of cancer immunotherapy. Efforts aimed at developing and engineering NK cell-based cancer immunotherapy require clean and efficient methods of cell isolation at both small and large scales. The new MARS® Bar system enables a new generation of large scale, magnetic CD56+/CD3- cell isolation […]

B cell isolation with MARS® Platform

Immunotherapy requires purified cells for a variety of experimental needs. For patients with protein deficiencies for whom gene therapy is not an option, B cells provide an excellent factory for producing immunoglobulin in lymphocytes or plasma cells. x`Obtaining a large number of B cells requires a cell isolation solution for both pre-clinical testing on a […]

Multiphysics innovation for high speed, high recovery, and high viability automated cell separation

INTRODUCTION Tumor biology, immunology, and immune-oncology from multi-omics at the single cell level have witnessed an unprecedented acceleration in recent years, with a major contribution of such speedup from new technologies and products bursting into the market. New technological solutions also contributed deterministically to the promise of cell-based therapy. However, conventional cell separation tools, such […]

Novel Multiphysics Cell Separation Platforms for Cell Therapy Development

INTRODUCTION In the past twenty years, cell therapy has made great success in treating patients and enormous efforts have been devoted to developing new drugs as well as improving the efficiency of manufacturing processes. New technological solutions with flexibility and scalability are desired to support the promise of cell-based therapy. MARS Cell Separation Platforms incorporate […]

NK cell isolation with MARS® Platform

Over the last years, NK cells have gained significant attention in the field of cancer immunotherapy and many efforts are emerging for developing and engineering NK cell-based cancer immunotherapy. Obtaining a large quantity of NK cells requires a democratized cell isolation solution for both pre-clinical and clinical applications. The new MARS Bar system enables a […]